Pharma giant Pfizer is setting its sights on the digital therapeutics space, inking a new strategic commercial partnership with Swedish startup Alex Therapeutics.
The joint effort will tap into Alex Therapeutics AI-based platform that integrates both cognitive behavioral therapy (CBT) and Acceptance and Commitment Therapy (ACT) with AI in order to personalize care. Initially the pair will focus...